Should I buy or sell Chemours stock right now?

8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last twelve months. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares. View CC analyst ratings or view top-rated stocks .

What is Chemours' stock price target for 2024?

8 analysts have issued 12 month price objectives for Chemours' shares. Their CC share price targets range from $25.00 to $40.00. On average, they anticipate the company's share price to reach $30.89 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price. View analysts price targets for CC or view top-rated stocks among Wall Street analysts .

How have CC shares performed in 2024?

Chemours' stock was trading at $31.54 at the start of the year. Since then, CC shares have decreased by 17.5% and is now trading at $26.03. View the best growth stocks for 2024 here .

When is Chemours' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024. View our CC earnings forecast .

How were Chemours' earnings last quarter?

The Chemours Company (NYSE:CC) released its earnings results on Friday, July, 28th. The specialty chemicals company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.09 by $0.01. The specialty chemicals company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.75 billion. Chemours had a positive trailing twelve-month return on equity of 51.73% and a negative net margin of 3.80%. During the same quarter in the previous year, the company posted $1.89 earnings per share.

How often does Chemours pay dividends? What is the dividend yield for Chemours?

Chemours declared a quarterly dividend on Monday, February 12th. Stockholders of record on Monday, February 26th will be paid a dividend of $0.25 per share on Friday, March 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.84%. The ex-dividend date of this dividend is Friday, February 23rd. Read our dividend analysis for CC .

Is Chemours a good dividend stock?

Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.78%. Read our dividend analysis for CC .

What ETFs hold Chemours' stock?

ETFs with the largest weight of Chemours (NYSE:CC) stock in their portfolio include ProShares Smart Materials ETF (TINT) , First Trust Materials AlphaDEX Fund (FXZ) , First Trust Dorsey Wright Momentum & Dividend ETF (DDIV) , First Trust Dorsey Wright Momentum & Value ETF (DVLU) , Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ) , Fidelity Fundamental Small-Mid Cap ETF (FSMO) , JPMorgan Active Value ETF (JAVA) and Avantis US Small Cap Value ETF (AVUV) .

What guidance has Chemours issued on next quarter's earnings?

Chemours updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.0 billion-$6.0 billion, compared to the consensus revenue estimate of $6.0 billion.

What is Mark Vergnano's approval rating as Chemours' CEO?

106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com . Mark Vergnano has an approval rating of 85% among the company's employees.

What other stocks do shareholders of Chemours own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T) , Pfizer (PFE) , DuPont de Nemours (DD) , NVIDIA (NVDA) , Cisco Systems (CSCO) , Micron Technology (MU) , Intel (INTC) , AbbVie (ABBV) , CVS Health (CVS) and Energy Transfer (ET) .

Who are Chemours' major shareholders?

Chemours' stock is owned by a number of retail and institutional investors. Top institutional investors include Portman Square Capital LLP (0.00%), Richelieu Gestion SA (0.06%), Alaska Permanent Fund Corp (0.06%), IMC Chicago LLC (0.00%) and Sunbelt Securities Inc. (0.00%). Insiders that own company stock include Alisha Bellezza , Alvenia Scarborough , David C Shelton , Denise Dignam , Edwin C Sparks, Edwin C Sparks , Mark Newman , Mark P Vergnano, Mark P Vergnano , Matthew S Abbott, Matthew S Abbott and Sameer Ralhan . View institutional ownership trends .

How do I buy shares of Chemours?

Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here .

NYSE:CC

Chemours (CC) Stock Price, News & Analysis

→ “Forget Tesla, this is Elon’s Next Big Thing” (From InvestorPlace) (Ad)

Free CC Stock Alerts

$26.03

-0.45 (-1.70%)

(As of 04/15/2024 ET)

Compare

Today's Range: $25.84
▼
$26.92
50-Day Range: $19.70
▼
$31.19
52-Week Range: $15.10
▼
$39.05

Volume: 982,300 shs
Average Volume: 1.93 million shs
Market Capitalization: $3.87 billion

P/E Ratio: N/A
Dividend Yield: 3.84%
Price Target: $30.89

Get Chemours alerts:

Chemours MarketRank™ Stock Analysis

Analyst Rating: Hold
2.25 Rating Score
Upside/Downside: 18.7% Upside
$30.89 Price Target
Short Interest: Healthy
3.32% of Float Sold Short
Dividend Strength: Moderate
Based on Four Factors
Sustainability: N/A
News Sentiment: 0.02
Based on 38 Articles This Week
Insider Trading: N/A
Proj. Earnings Growth: 48.43%
From $2.23 to $3.31 Per Share

Overall MarketRank^™

New Rank-Based ScoringMarketRank^™ is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.50 out of 5 stars

Basic Materials Sector

100th out of 166 stocks

Chemicals & Allied Products Industry

9th out of 13 stocks

2.1

Analyst's Opinion

Consensus Rating
Chemours has received a consensus rating of Hold. The company's average rating score is 2.25, and is based on 2 buy ratings, 6 hold ratings, and no sell ratings.
Amount of Analyst Coverage
Chemours has only been the subject of 3 research reports in the past 90 days.

3.0

Short Interest

Percentage of Shares Shorted
3.32% of the float of Chemours has been sold short.
Short Interest Ratio / Days to Cover
Chemours has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.
Change versus previous month

2.5

Dividend Strength

Dividend Leadership
Chemours is a leading dividend payer. It pays a dividend yield of 3.78%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
Chemours does not have a long track record of dividend growth.
Dividend Sustainability
Based on earnings estimates, Chemours will have a dividend payout ratio of 30.21% next year. This indicates that Chemours will be able to sustain or increase its dividend.

N/A

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score
There is no current Upright™ data available for CC.

2.2

News and Social Media Coverage

News Sentiment
Chemours has a news sentiment score of 0.02. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.40 average news sentiment score of Basic Materials companies.
News Coverage This Week
MarketBeat has tracked 38 news articles for Chemours this week, compared to 10 articles on an average week.
Search Interest
Only 21 people have searched for CC on MarketBeat in the last 30 days. This is a decrease of -13% compared to the previous 30 days.
MarketBeat Follows
9 people have added Chemours to their MarketBeat watchlist in the last 30 days. This is an increase of 13% compared to the previous 30 days.

1.7

Company Ownership

Insider Buying vs. Insider Selling
In the past three months, Chemours insiders have not sold or bought any company stock.
Percentage Held by Insiders
Only 1.63% of the stock of Chemours is held by insiders.
Percentage Held by Institutions
76.26% of the stock of Chemours is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

1.9

Earnings and Valuation

Earnings Growth
Earnings for Chemours are expected to grow by 48.43% in the coming year, from $2.23 to $3.31 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of Chemours is -16.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Earnings Ratio vs. Sector
The P/E ratio of Chemours is -16.79, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Price to Book Value per Share Ratio
Chemours has a P/B Ratio of 5.23. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

See Top Rated MarketRank™ Stocks Here

Ad InvestorPlace

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

And you could go along for the ride if you make this one simple move.

About Chemours Stock (NYSE:CC)

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging. The Thermal & Specialized Solutions segment offers of refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents. The Advanced Performance Materials segment products portfolio includes various industrial resins, specialty products, membranes, and coatings for consumer electronics, semiconductors, digital communications, transportation, energy, oil and gas, and medical, and other applications. The company sells its products through direct and indirect channels, as well as through a network of resellers and distributors. The Chemours Company was incorporated in 2014 and is headquartered in Wilmington, Delaware.

CC Stock Price History

30 days | 90 days | 365 days | Advanced Chart

CC Stock News Headlines

April 1, 2024 | marketbeat.com

Court approves 3M settlement over 'forever chemicals' in public drinking water systems

Chemical manufacturer 3M will begin payments starting in the third quarter to many U.S. public drinking water systems as part of a multi-billion-dollar settlement over contamination with potentially harmful compounds used in firefighting foam and several consumer products

April 15, 2024 | markets.businessinsider.com

CC DEADLINE ALERT: Kessler Topaz Meltzer & Check, LLP Announces Deadline in The Chemours Company Securities Fraud Class Action Lawsuit

April 16, 2024 | InvestorPlace (Ad)

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

April 15, 2024 | prnewswire.com

Investors who lost money on The Chemours Company (CC) should contact Levi & Korsinsky about pending Class Action - CC

April 14, 2024 | markets.businessinsider.com

Investor Reminder: Kessler Topaz Meltzer & Check, LLP Reminds Investors of Securities Fraud Class Action Lawsuit Filed Against The Chemours Company

April 14, 2024 | markets.businessinsider.com

DEADLINE REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Chemours

April 12, 2024 | prnewswire.com

THE CHEMOURS COMPANY SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against The Chemours Company - CC

April 12, 2024 | stockhouse.com

SHAREHOLDER ACTION NOTICE: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm

April 16, 2024 | InvestorPlace (Ad)

Elon Musk’s ChatGPT Could Soon Mint New Millionaires

Elon Musk made $180 million on PayPal… $47 Billion on SpaceX…and $94.2 Billion on Tesla. He’s about to shock the world again with his version of ChatGPT.

April 12, 2024 | prnewswire.com

CC Investors Have Opportunity to Lead The Chemours Company Securities Fraud Lawsuit

April 12, 2024 | prnewswire.com

SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against The Chemours Company - CC

April 12, 2024 | markets.businessinsider.com

IMPORTANT DEADLINE ALERT: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm

April 12, 2024 | prnewswire.com

The Gross Law Firm Notifies Shareholders of The Chemours Company(CC) of a Class Action Lawsuit and an Upcoming Deadline

April 12, 2024 | americanbankingnews.com

Q1 2024 Earnings Forecast for The Chemours Company (NYSE:CC) Issued By Zacks Research

April 11, 2024 | prnewswire.com

Kessler Topaz Meltzer & Check, LLP Reminds Shareholders of Deadline in Securities Fraud Class Action Lawsuit Filed Against The Chemours Company

April 11, 2024 | markets.businessinsider.com

SHAREHOLDER ACTION REMINDER: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm

April 11, 2024 | stockhouse.com

INVESTIGATION NOTICE: Scott+Scott Attorneys at Law LLP Investigates The Chemours Company's Directors and Officers for Breach of Fiduciary Duties - CC

April 11, 2024 | americanbankingnews.com

Chemours (NYSE:CC) Shares Gap Up to $27.05

April 11, 2024 | americanbankingnews.com

Zacks Research Weighs in on The Chemours Company's Q3 2024 Earnings (NYSE:CC)

April 10, 2024 | prnewswire.com

ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages The Chemours Company Investors to Secure Counsel Before Important Deadline in Securities Class Action - CC

April 10, 2024 | finance.yahoo.com

The Chemours Company (CC)

April 10, 2024 | markets.businessinsider.com

SHAREHOLDER ACTION ALERT: The Schall Law Firm Encourages Investors in The Chemours Company with Losses to Contact the Firm

April 10, 2024 | finance.yahoo.com

EPA Sets US’s First Drinking Water Standards to Limit Toxic PFAS

April 10, 2024 | prnewswire.com

Class Action Filed Against The Chemours Company (CC) - May 20, 2024 Deadline to Join - Contact Levi & Korsinsky

April 10, 2024 | americanbankingnews.com

Chemours (NYSE:CC) Upgraded by BMO Capital Markets to "Outperform"

April 9, 2024 | stockhouse.com

INVESTIGATION ALERT: Scott+Scott Attorneys at Law LLP Investigates The Chemours Company's Directors and Officers for Breach of Fiduciary Duties - CC

April 9, 2024 | markets.businessinsider.com

Why Chemours Gets A Double Upgrade From This Analyst

See More Headlines

Receive CC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Chemours and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 7/28/2023
Ex-Dividend for 3/15 Dividend: 2/23/2024
Dividend Payable: 3/15/2024
Today: 4/15/2024
Next Earnings (Estimated): 4/25/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NYSE
Sector: Basic Materials
Industry: Chemicals & allied products
Sub-Industry: N/A
Current Symbol: NYSE:CC
CUSIP: N/A
CIK: 1627223
Web: www.chemours.com
Phone: (302) 773-1000
Fax: N/A
Employees: 6,200
Year Founded: N/A

Price Target and Rating

Average Stock Price Target: $30.89
High Stock Price Target: $40.00
Low Stock Price Target: $25.00
Potential Upside/Downside: +18.7%
Consensus Rating: Hold
Rating Score (0-4): 2.25
Research Coverage: 8 Analysts

Profitability

EPS (Most Recent Fiscal Year): ($1.55)
Trailing P/E Ratio: N/A
Forward P/E Ratio: 11.67
P/E Growth: N/A
Net Income: $-238,000,000.00
Net Margins: -3.80%
Pretax Margin: -5.28%
Return on Equity: 51.73%
Return on Assets: 5.81%

Debt

Debt-to-Equity Ratio: 5.40
Current Ratio: 1.54
Quick Ratio: 1.00

Sales & Book Value

Annual Sales: $6.03 billion
Price / Sales: 0.64
Cash Flow: $4.91 per share
Price / Cash Flow: 5.30
Book Value: $4.98 per share
Price / Book: 5.23

Miscellaneous

Outstanding Shares: 148,802,000
Free Float: 146,454,000
Market Cap: $3.87 billion
Optionable: Optionable
Beta: 2.00

7 AI Stocks to Invest In: An Introduction to AI Investing For Self-Directed Investors

As the AI market heats up, investors who have a vision for artificial intelligence have the potential to see real returns. Learn about the industry as a whole as well as seven companies that are getting work done with the power of AI.

Get This Free Report

Key Executives

Ms. Denise M. Dignam (Age 58)
Interim CEO & President of Titanium Technologies
Comp: $977.06k
Mr. Matthew S. Abbott (Age 47)
Interim CFO and Principal Financial & Accounting Officer
Mr. Brandon Ontjes
Vice President of FP&A and Investor Relations
Ms. Kristine M. Wellman (Age 55)
Senior VP, General Counsel & Company Secretary
Ms. Alvenia Scarborough (Age 50)
Senior VP of Corporate Communications & Chief Brand Officer
Mr. Ron Charles
Senior Vice President of People
Mr. Aditya Beri
Interim President of Titanium Technologies & Chemical Solutions Business
Mr. Gerardo Familiar Calderon
President of Advanced Performance Materials
Ms. Amber Wellman Ph.D.
Chief Sustainability Officer
Mr. Joseph Martinko
President of Thermal & Specialized Solutions

Key Competitors

View All Competitors

Insiders & Institutions

View All Insider Transactions
View All Institutional Transactions

CC Stock Analysis - Frequently Asked Questions

Should I buy or sell Chemours stock right now?: 8 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Chemours in the last twelve months. There are currently 6 hold ratings and 2 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CC shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CC, but not buy additional shares or sell existing shares.
View CC analyst ratings or view top-rated stocks.
What is Chemours' stock price target for 2024?: 8 analysts have issued 12 month price objectives for Chemours' shares. Their CC share price targets range from $25.00 to $40.00. On average, they anticipate the company's share price to reach $30.89 in the next twelve months. This suggests a possible upside of 18.7% from the stock's current price.
View analysts price targets for CC or view top-rated stocks among Wall Street analysts.
How have CC shares performed in 2024?: Chemours' stock was trading at $31.54 at the start of the year. Since then, CC shares have decreased by 17.5% and is now trading at $26.03.
View the best growth stocks for 2024 here.
When is Chemours' next earnings date?: The company is scheduled to release its next quarterly earnings announcement on Thursday, April 25th 2024.
View our CC earnings forecast.
How were Chemours' earnings last quarter?: The Chemours Company (NYSE:CC) released its earnings results on Friday, July, 28th. The specialty chemicals company reported $1.10 earnings per share for the quarter, beating analysts' consensus estimates of $1.09 by $0.01. The specialty chemicals company had revenue of $1.64 billion for the quarter, compared to analysts' expectations of $1.75 billion. Chemours had a positive trailing twelve-month return on equity of 51.73% and a negative net margin of 3.80%. During the same quarter in the previous year, the company posted $1.89 earnings per share.
How often does Chemours pay dividends? What is the dividend yield for Chemours?: Chemours declared a quarterly dividend on Monday, February 12th. Stockholders of record on Monday, February 26th will be paid a dividend of $0.25 per share on Friday, March 15th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 3.84%. The ex-dividend date of this dividend is Friday, February 23rd.
Read our dividend analysis for CC.
Is Chemours a good dividend stock?: Chemours (NYSE:CC) pays an annual dividend of $1.00 per share and currently has a dividend yield of 3.78%.
Read our dividend analysis for CC.

What ETFs hold Chemours' stock?: ETFs with the largest weight of Chemours (NYSE:CC) stock in their portfolio include ProShares Smart Materials ETF (TINT), First Trust Materials AlphaDEX Fund (FXZ), First Trust Dorsey Wright Momentum & Dividend ETF (DDIV), First Trust Dorsey Wright Momentum & Value ETF (DVLU), Invesco Dorsey Wright Basic Materials Momentum ETF (PYZ), Fidelity Fundamental Small-Mid Cap ETF (FSMO), JPMorgan Active Value ETF (JAVA) and Avantis US Small Cap Value ETF (AVUV).
What guidance has Chemours issued on next quarter's earnings?: Chemours updated its FY 2023 earnings guidance on Thursday, February, 29th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.0 billion-$6.0 billion, compared to the consensus revenue estimate of $6.0 billion.
What is Mark Vergnano's approval rating as Chemours' CEO?: 106 employees have rated Chemours Chief Executive Officer Mark Vergnano on Glassdoor.com. Mark Vergnano has an approval rating of 85% among the company's employees.
What other stocks do shareholders of Chemours own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Chemours investors own include AT&T (T), Pfizer (PFE), DuPont de Nemours (DD), NVIDIA (NVDA), Cisco Systems (CSCO), Micron Technology (MU), Intel (INTC), AbbVie (ABBV), CVS Health (CVS) and Energy Transfer (ET).
Who are Chemours' major shareholders?: Chemours' stock is owned by a number of retail and institutional investors. Top institutional investors include Portman Square Capital LLP (0.00%), Richelieu Gestion SA (0.06%), Alaska Permanent Fund Corp (0.06%), IMC Chicago LLC (0.00%) and Sunbelt Securities Inc. (0.00%). Insiders that own company stock include Alisha Bellezza, Alvenia Scarborough, David C Shelton, Denise Dignam, Edwin C Sparks, Edwin C Sparks, Mark Newman, Mark P Vergnano, Mark P Vergnano, Matthew S Abbott, Matthew S Abbott and Sameer Ralhan.
View institutional ownership trends.
How do I buy shares of Chemours?: Shares of CC stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NYSE:CC) was last updated on 4/16/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Chemours (CC) Stock Price, News & Analysis

Chemours MarketRank™ Stock Analysis

Overall MarketRank™

Analyst's Opinion

Short Interest

Percentage of Shares Shorted

Short Interest Ratio / Days to Cover

Change versus previous month

Dividend Strength

Sustainability and ESG

Overall ESG (Environmental, Social, and Governance) Score

News and Social Media Coverage

News Sentiment

News Coverage This Week

Search Interest

MarketBeat Follows

Company Ownership

Earnings and Valuation

About Chemours Stock (NYSE:CC)

CC Stock Price History

CC Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Price Target and Rating

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Insiders & Institutions

CC Stock Analysis - Frequently Asked Questions

Overall MarketRank^™